Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,522Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Newbury Pharmaceuticals Ab

02 3Novartis Europharm Limited

03 1Novartis Pharma Schweiz Ag

04 1Stada Sl Laboratory

05 1Teva Gmbh

06 4Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Film Coated Tablet

Dosage Strength : 250mg

Packaging :

Approval Date : 23/05/2007

Application Number : 57937

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Lapatinibditosilatmonohydrat

Brand Name : Tyverb

Dosage Form : Film Coated Tablet

Dosage Strength : 250mg

Packaging :

Approval Date : 10/06/2008

Application Number : 20061121000199

Regulatory Info : Approved

Registration Country : Sweden

blank

03

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Film Coated Tablet

Dosage Strength : 250MG

Packaging :

Approval Date : 2011-03-16

Application Number : 07440005

Regulatory Info : Authorized

Registration Country : Spain

blank

04

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Lapatinib Stada

Dosage Form : Film Coated Tablet

Dosage Strength : 250MG

Packaging :

Approval Date : 2022-08-25

Application Number : 88047

Regulatory Info : Authorized

Registration Country : Spain

blank

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Lapatinibditosilatmonohydrat

Brand Name : Lapatinib Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 250mg

Packaging :

Approval Date : 25/08/2023

Application Number : 20211130000172

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Country
OTS 2025
Not Confirmed
arrow

Country
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Lapatinib 250Mg 70 Units' Oral Use

Dosage Strength : 70 cpr riv 250 mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Country
OTS 2025
Not Confirmed
arrow

Country
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Lapatinib 250Mg 84 Combined Oral Use

Dosage Strength : 84 cpr riv 250 mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Country
OTS 2025
Not Confirmed
arrow

Country
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Antic-calc Tablet

Dosage Strength : 250 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Country
OTS 2025
Not Confirmed
arrow

Country
arrow
OTS 2025
Not Confirmed

Lapatinib

Brand Name : Tyverb

Dosage Form : Antic-calc Tablet

Dosage Strength : 250 mg

Packaging : Box of plastic

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

Newbury Pharmaceuticals Ab

Country
OTS 2025
Not Confirmed
arrow

Newbury Pharmaceuticals Ab

Country
arrow
OTS 2025
Not Confirmed

Lapatinibditosilatmonohydrat

Brand Name : Lapatinib Newbury

Dosage Form : Film Coated Tablet

Dosage Strength : 250mg

Packaging :

Approval Date : 23/03/2023

Application Number : 20220307000013

Regulatory Info : Approved

Registration Country : Sweden

blank